# Liddy McCall

> Liddy McCall is a Series B investor at Yuuwa Capital (Perth) backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Yuuwa Capital](https://shizune.co/investors/profile/yuuwa-capital)
- Location: Perth, Australia
- Total investments: 1
- Last investment: Feb 2013
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://au.linkedin.com/pub/liddy-mccall/4/a28/623

Liddy McCall is a Series B investor at Yuuwa Capital in Perth focused on Medical and Health Care. Liddy has been involved in technology commercialisation for over 10 years.In 2002, she co-founded Tessitura Pty Ltd with fellow Yuuwa Capital Investment Director, Dr James Williams, to provide commercialisation support to biotechnology companies. She has been on the Board of biotechnology companies involved in drug discovery, formulation andrepositioning.She was a co-founder of the iCeutica Group and Dimerix Bioscience Pty Ltd. Liddy has been involved in taking companies from proof-of-concept through to goals including marketed medical device (FDA, CE Mark, TGA); successful completion of clinical drug trials; and early revenue generation through pharmaceutical adoption of new technologies.Prior roles include Associate Director, Corporate Advisory Group at Macquarie Bank. Liddy was based in Sydney and Toronto focusing on mergers, acquisitions, divestments and corporate advisory transactions across a range of industries. Liddy has been admitted as a Barrister and Solicitor in various Australian jurisdictions. She has prior experience working as a lawyer and in funds management.Liddy is a Director of Yuuwa investee companies: iCetana Pty Ltd, Adalta Pty Ltd and GordianTec Pty Ltd.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PolyActiva | PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers. | $6.4M | Series B | Feb 19, 2013 |  |

1 of 1 investments shown.

## Co-investors
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 1 deal together
- [Medical Research Commercialisation Fund (MRCF)](https://shizune.co/investors/profile/medical-research-commercialisation-fund-mrcf) — VC Fund, 1 deal together

## About Yuuwa Capital

VC Fund · Perth, Australia

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

3 contacts available at Yuuwa Capital.

| Name | Title | Profile |
| --- | --- | --- |
| James Williams | Co-Founder and and Investment Director | https://shizune.co/investors/profile/james-williams-5 |
| Liddy McCall | Co-Founder and Investment Director | https://shizune.co/investors/profile/liddy-mccall |
| Matthew Macfarlane | Co-Founder and Investment Director | https://shizune.co/investors/profile/matthew-macfarlane |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Liddy McCall invest in?

Liddy McCall invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Liddy McCall last invest?

The most recent investment recorded for Liddy McCall closed in Feb 2013. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co